Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Arix Bioscience raises £100m in IPO Global healthcare and life science company Arix Bioscience has raised £100m in its Initial Public Offering (IPO) on the main market of the London Stock Exchange.
Production & Manufacturing > Manufacturing > News
Momenta announces FDA warning letter to contracted Glatopa’s fill/finish manufacturer Momenta Pharmaceuticals has announced that Pfizer, Sandoz’s contracted Glatopa (glatiramer acetate injection) fill/finish manufacturing partner has received a warning letter from the FDA.
Production & Manufacturing > Manufacturing > News Takeda acquires Ariad Pharmaceuticals Takeda Pharmaceutical has completed its acquisition of Ariad Pharmaceuticals for $24.00 per share in cash.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Pfizer, Flynn appeal against UK regulator's £89.4m fine for epilepsy drug price hike
By PBR Staff Writer
Pfizer and Flynn Pharma have appealed against the £89.4m fine imposed by the UK Competition and Markets Authority (CMA) for charging excessive and unfair prices for an anti-epilepsy drug.
Production & Manufacturing > Manufacturing > News
German pharma company Stada confirms takeover bid from two firms
By PBR Staff Writer
German drug maker Stada Arzneimittel has received two takeover proposals including a €3.5bn proposal from private equity group Cinven Partners.
Production & Manufacturing > Manufacturing > News
US appeals court allows Regeneron, Sanofi to continue selling cholesterol drug
By PBR Staff Writer
A US appeals court has stayed an order that could have prevented Regeneron Pharmaceuticals and Sanofi from selling their cholesterol drug, Praluent.
Production & Manufacturing > Manufacturing > News
Biotech companies oppose Trump’s immigration order
By PBR Staff Writer
Chief executives of over 160 biotech companies in the US have signed a letter opposing President Donald Trump's immigration order.
Production & Manufacturing > Manufacturing > News
FDA accepts Intellipharmaceutics’ NDA for Rexista to treat moderate to severe pain
The US Food and Drug Administration has accepted for filing of Intellipharmaceutics International’s New Drug Application ("NDA") seeking authorization to market its Rexista abuse-deterrent oxycodone hydrochloride extended release tablets in the 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg strengths.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests